Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.

Regeneron to acquire 23andMe’s core assets for $256m amid court-supervised bankruptcy sale

Pallavi Madhiraju- May 19, 2025 0

Regeneron to acquire 23andMe’s core assets for $256M in a court-supervised deal. Learn how this biotech merger impacts DNA data privacy, investor sentiment, and the ... Read More

Salesforce and Takeda partner to transform pharma engagement with AI-driven Life Sciences Cloud platform

Pallavi Madhiraju- May 19, 2025 0

Discover how Salesforce and Takeda are redefining pharma engagement using AI-powered Life Sciences Cloud. Learn how data, AI, and patient outcomes align. Read More

Halozyme Therapeutics stock rises 6.27% after beating Q1 expectations, raising 2025 outlook

Pallavi Madhiraju- May 18, 2025 0

Halozyme Therapeutics stock rose as Q1 earnings beat expectations and 2025 guidance improved. See how ENHANZE® drives royalty growth and future prospects. Read More

How do Vutrisiran’s HELIOS-B results compare with historical standards in ATTR-CM treatment?

Pallavi Madhiraju- May 18, 2025 0

Alnylam’s vutrisiran reduces cardiovascular mortality and urgent heart failure visits in ATTR-CM, reinforcing AMVUTTRA’s first-line potential. Read key data now. Read More

Be Biopharma reports positive preclinical data for BE-102 in hypophosphatasia

Pallavi Madhiraju- May 18, 2025 0

Be Biopharma shares preclinical results for BE-102, a B cell medicine in development for treating hypophosphatasia. Read about its novel approach. Read More

Apellis Pharmaceuticals gains 6.66% as investors bet on Q2 trial update and long-term pipeline potential

Pallavi Madhiraju- May 18, 2025 0

Apellis Pharmaceuticals stock jumped 6.66% as investors bet on key trial updates and undervalued biotech potential. Will FDA decisions drive more upside? Read More

CRISPR Therapeutics stock jumps 6.77% as institutional rebalancing favors gene-editing names

Pallavi Madhiraju- May 17, 2025 0

CRISPR Therapeutics stock rose 6.77% as funds rotated back into gene-editing names. Find out what’s driving the rebound and what lies ahead for CRSP. Read More

Zai Lab stock rallies on regulatory optimism in China’s oncology sector

Pallavi Madhiraju- May 17, 2025 0

Zai Lab stock jumps 7.6% on China FDA review optimism for its oncology drugs, as cross-border biotech sentiment improves. Read the full investor analysis. Read More

Be Biopharma unveils promising preclinical data for BE-102 B cell therapy targeting hypophosphatasia

Pallavi Madhiraju- May 17, 2025 0

In a notable advancement for genetic bone disorder therapies, Be Biopharma Inc. has presented new preclinical data for BE-102, its lead B Cell Medicine (BCM) ... Read More

Tonix Pharmaceuticals stock up over 20%: Can TNX-102 SL and TNX-1700 fuel a turnaround in 2025?

Pallavi Madhiraju- May 17, 2025 0

Tonix Pharmaceuticals surged 21% despite deep losses, as retail traders bet on TNX-102 SL’s FDA nod and cancer pipeline momentum. Read the full story. Read More

12345...27830 / 2778 Posts